Diamedica Therapeutics Stock Price Patterns
| DMAC Stock | USD 8.04 0.43 5.08% |
Momentum 39
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.17) | EPS Estimate Current Year (0.72) | EPS Estimate Next Year (0.76) | Wall Street Target Price 15.5 | EPS Estimate Current Quarter (0.16) |
Using DiaMedica Therapeutics hype-based prediction, you can estimate the value of DiaMedica Therapeutics from the perspective of DiaMedica Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards DiaMedica Therapeutics using DiaMedica Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards DiaMedica using crowd psychology based on the activity and movement of DiaMedica Therapeutics' stock price.
DiaMedica Therapeutics Implied Volatility | 1.37 |
DiaMedica Therapeutics' implied volatility exposes the market's sentiment of DiaMedica Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if DiaMedica Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that DiaMedica Therapeutics stock will not fluctuate a lot when DiaMedica Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in DiaMedica Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying DiaMedica because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
DiaMedica Therapeutics after-hype prediction price | USD 8.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current DiaMedica contract
Based on the Rule 16, the options market is currently suggesting that DiaMedica Therapeutics will have an average daily up or down price movement of about 0.0856% per day over the life of the 2026-04-17 option contract. With DiaMedica Therapeutics trading at USD 8.04, that is roughly USD 0.006884 . If you think that the market is fully incorporating DiaMedica Therapeutics' daily price movement you should consider acquiring DiaMedica Therapeutics options at the current volatility level of 1.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
DiaMedica | Build AI portfolio with DiaMedica Stock |
DiaMedica Therapeutics After-Hype Price Density Analysis
As far as predicting the price of DiaMedica Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in DiaMedica Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of DiaMedica Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
DiaMedica Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting DiaMedica Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on DiaMedica Therapeutics' historical news coverage. DiaMedica Therapeutics' after-hype downside and upside margins for the prediction period are 3.30 and 12.78, respectively. We have considered DiaMedica Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
DiaMedica Therapeutics is moderately volatile at this time. Analysis and calculation of next after-hype price of DiaMedica Therapeutics is based on 3 months time horizon.
DiaMedica Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as DiaMedica Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DiaMedica Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DiaMedica Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.41 | 4.77 | 0.01 | 0.03 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
8.04 | 8.04 | 0.00 |
|
DiaMedica Therapeutics Hype Timeline
DiaMedica Therapeutics is currently traded for 8.04. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.03. DiaMedica is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.41%. %. The volatility of related hype on DiaMedica Therapeutics is about 6913.04%, with the expected price after the next announcement by competition of 8.01. About 26.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.71. DiaMedica Therapeutics last dividend was issued on the 15th of November 2018. The entity had 1:20 split on the 15th of November 2018. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out DiaMedica Therapeutics Basic Forecasting Models to cross-verify your projections.DiaMedica Therapeutics Related Hype Analysis
Having access to credible news sources related to DiaMedica Therapeutics' direct competition is more important than ever and may enhance your ability to predict DiaMedica Therapeutics' future price movements. Getting to know how DiaMedica Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how DiaMedica Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALT | Altimmune | 0.05 | 2 per month | 5.09 | 0.1 | 9.80 | (5.05) | 33.75 | |
| GALT | Galectin Therapeutics | (0.50) | 11 per month | 0.00 | (0.12) | 9.46 | (8.89) | 43.49 | |
| ENGN | enGene Holdings Common | 0.06 | 4 per month | 4.62 | 0.06 | 11.36 | (7.21) | 61.40 | |
| IMAB | IMAB Old | (0.58) | 5 per month | 4.63 | 0.06 | 10.53 | (8.92) | 33.43 | |
| ANNX | Annexon | 0.02 | 10 per month | 3.42 | 0.17 | 11.30 | (7.54) | 35.10 | |
| DRTS | Alpha Tau Medical | 0.04 | 7 per month | 3.62 | 0.16 | 10.48 | (6.42) | 28.89 | |
| KRRO | Frequency Therapeutics | 0.30 | 7 per month | 0.00 | (0.03) | 12.24 | (6.62) | 91.55 | |
| DSGN | Design Therapeutics | 0.26 | 8 per month | 3.63 | 0.14 | 9.28 | (5.98) | 18.90 | |
| DBVT | DBV Technologies | (0.40) | 9 per month | 4.01 | 0.09 | 10.53 | (6.81) | 36.36 | |
| GNLX | Genelux Common | 0.06 | 4 per month | 0.00 | (0.20) | 5.67 | (11.87) | 37.06 |
DiaMedica Therapeutics Additional Predictive Modules
Most predictive techniques to examine DiaMedica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DiaMedica using various technical indicators. When you analyze DiaMedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About DiaMedica Therapeutics Predictive Indicators
The successful prediction of DiaMedica Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DiaMedica Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DiaMedica Therapeutics based on analysis of DiaMedica Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to DiaMedica Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DiaMedica Therapeutics's related companies. | 2025 | 2026 (projected) | Payables Turnover | 0.007018 | 0.006202 | Days Of Inventory On Hand | 0.0914 | 0.08 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for DiaMedica Stock analysis
When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |